Related Experiment Videos

[Effect of histamine and diprazin on the course of experimental amyloidosis in mice]

Arkhiv Patologii
|January 1, 1975
PubMed

Insights

Histamine promotes amyloidosis development in mice by affecting vascular permeability, while the antihistamine diprazine inhibits it. This suggests impaired vascular integrity plays a role in amyloidosis pathogenesis.

Area of Science:

  • Pharmacology
  • Pathology
  • Immunology

Background:

  • Amyloidosis is a group of diseases characterized by the deposition of amyloid protein aggregates in various organs.
  • Vascular-tissue permeability is crucial in regulating the transport of substances between blood and tissues.
  • Histamine is a known mediator of inflammation and vascular permeability.

Purpose of the Study:

  • To investigate the effect of histamine and diprazine on amyloidosis development in mice.
  • To explore the role of altered vascular-tissue permeability in the pathogenesis of amyloidosis.

Main Methods:

  • Experiments were conducted on 33 C57Bl mice.
  • Mice were administered histamine and diprazine (an antihistamine).
  • Morphometric methods and statistical analysis were used to assess amyloidosis development and vascular changes.

Main Results:

  • Histamine administration stimulated amyloidosis development, causing vascular disorders and mast-cell degranulation.
  • Diprazine inhibited amyloidogenesis in mice.
  • Statistically significant differences were observed between experimental and control groups.

Conclusions:

  • Histamine promotes amyloidosis, likely by increasing vascular-tissue permeability.
  • Diprazine exhibits inhibitory effects on amyloidogenesis.
  • Impaired vascular-tissue permeability is implicated in the pathogenesis of amyloidosis.

Related Concept Videos